The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.
Cell & Gene: The Podcast
00:00
Rapid Advancements in Adenovector-Based Therapies Amidst Challenges
This chapter explores the progress of a company focused on adenovector-based therapies, showcasing their journey from discovery to receiving FDA breakthrough designation during the COVID-19 pandemic. It highlights the potential life-changing impact of their treatments for patients with severe health challenges and the significance of their ongoing work.
Transcript
Play full episode
